Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All News and Research Articles

NIH HEAL initiative will aim to reduce over-prescription of opioids, as well as misuse and addiction, and accelerate development of non-opioid therapies
Miscounting prescription and illicit opioids together resulted in the CDC overdose rate to be too high.
Connecting psychological and somatic pain symptoms to women's pain syndromes such as dysmenorrhea and noncyclic pelvic pain
An international group of clinicians reviews what primary care and non-pain experts need to know about pain chronification
Survey of surgical program directors reveals knowledge gap in state policies regarding opioid prescribing.
Kentucky’s two-year budget, which still faces State Senate approval, may include a 25-cent tax on each dose of opioid dose sold into the state
An FDA committee has recommended approval of lofexidine, a selective alpha 2-adrenergic receptor agonist that reduces the release of norepinephrine, for the mitigation of opioid withdrawal symptoms
Symproic may ease opioid-induced constipation in patients with nonmalignant chronic pain without analgesia interference.
CBT, ACT and multimodal approaches are shown to be best approaches to help patients from pain catastrophizing.
Can the Trump administration proposals, including federal funding and public health education, end the opioid addiction, abuse, and misuse epidemic in the United States?
Non-opioid analgesic lidocaine patch may relieve post-herpetic neuralgia (post-shingles pain) for up to 12 hours.
Purdue Pharma LP, leading opioid manufacturer, aims to help healthcare providers better understand and assess chronic pain through research grants in virtual reality, cognitive functioning, and electroencephalograph alpha activity
Recent FDA seizures of kratom show safety and public health risks for opioid treatment.
Patients with traumatic brain injury or post-concussion may experience pain far beyond headache pain, so a full body workup is warranted.
Indications of three distinct and differing synovial subtypes mean that pain may differ between patients.